RxDB
ICD-10-CM Codes Browse (Tabular) Diagnostic External Drug Neoplasm

T42.8X5A – Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter

Overview

Coding Notes

Active
Billable, valid for HIPAA-covered transactions

GEM Conversion to ICD-9 CM

Fs: 10111 – Unspecified adverse effect of other drug, medicinal and biological substance
Fs: 10112 – Anti-parkinsonism drugs causing adverse effects in therapeutic use

MDC / MS-DRG Reference

FULL TERM NEONATE WITH MAJOR PROBLEMS
POISONING AND TOXIC EFFECTS OF DRUGS WITH MCC
POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MCC

Sibling Codes

Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter
Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela

Parent Sibling Codes

Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, accidental (unintentional)
Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, intentional self-harm
Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, assault
Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, undetermined
Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants
Underdosing of antiparkinsonism drugs and other central muscle-tone depressants

Codes with Same Suffix

Adverse effect of other systemic antibiotics, initial encounter
Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter
Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
Adverse effect of other psychotropic drugs, initial encounter
Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
Adverse effect of other primarily systemic and hematological agents, initial encounter
Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter
Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter
Adverse effect of other topical agents, initial encounter
Adverse effect of diagnostic agents, initial encounter